31st Annual TNP Conference Workshop WS05 Evaluation - Hormone Therapy

Speaker: Terri DeNeui
Thursday, September 5, 2019

Question Title

* 1. WS05: As a result of my participation in Hormone Therapy, I am better to:

  Strongly Disagree Disagree Agree Strongly Agree
Evidence based presentation of the role of sex hormones and sex hormone therapy in all body systems: neurological, cardiovascular, psychological, musculoskeletal and reproductive.
Review of the commonly prescribed sex hormone modalities and recent guidelines such as NAMS, ACOG and Endocrine Society.
 Evidence based solutions to address diagnosing deficiencies and prescribing of sex hormones ethically, safely, and effectively in both women and men.
Nuts and bolts of legal documentation: Clinic protocols, chart documentation, informed consent, and as testosterone is a controlled substance, utilization of DEA logs for controlled substance use in office will be reviewed

Question Title

* 2. The teaching methods used were appropriate to the objectives.

Question Title

* 3. The presenter demonstrated experiential knowledge of the topic.

Question Title

* 4. The individual objectives/content topic were cohesive with one another.

Question Title

* 5. The content of the program was fair and balanced.

Question Title

* 6. The content of the program was free of commercial bias.

Question Title

* 7. Speaker(s) fully disclosed any conflict of interest and discussion of off-label usage of medication and/or medical devices at beginning of, or during the presentation.

Question Title

* 8. I would recommend this speaker for future conference.

T